Survey data from a national poll indicate rising cannabis use in older adults, as access to cannabis increases across the country.
Cannabis use among older adults in the US increased since the COVID-19 pandemic in 2020, according to a study published in the journal Cannabis and Cannabinoid Research in November 2023 (1). Noting that there has been a lack of research in this area since 2019, the study, titled “Prevalence and Frequency of Cannabis Use Among Adults Ages 50–80 in the United States,” examined survey data from the National Poll on Healthy Aging (1). In the survey, 2,000 Americans answered questions about cannabis use over the course of the year (1). The study did not separate cannabis by medical or recreational uses (3).
“Among 2023 participants aged 50–80 (52.7% female), 12.1% reported cannabis use in the past year,” stated the Results in the Abstract (1). “Among those who reported cannabis use, 34.2% reported using cannabis products 4 or more days per week.”
The study also found that the respondents who used alcohol, or who were unemployed and unmarried were more likely to report cannabis use, while those who identified as Hispanic or “other” ethnicity were less likely to do so compared to those who identified as white (1).
“As the stress of the pandemic and the increased legalization of cannabis by states converged, our findings suggest cannabis use increased among older adults nationally,” stated Anne Fernandez, PhD, with the Addiction Center, Department of Psychiatry at the University of Michigan (3). “Older adults represent a vulnerable age group for cannabis use due to interactions with medications, risky driving, cannabis-related mental health impacts and increased possibility of falls and memory issues.”
As part of the conclusion of the study, the authors suggested more focus by medical professionals and policymakers on the health effects and risks for this population that uses cannabis (1).
References
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.